Buprenorphine And Naloxone Film
Product Images NDC 67296-1933

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-1933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

12mg-3mg-carton (12mg 3mg Carton)

12mg-3mg-carton (12mg 3mg Carton)
FDA Label Image

12mg-3mg-pouch (12mg 3mg Pouch)

12mg-3mg-pouch (12mg 3mg Pouch)
FDA Label Image

2mg-0pt5mg-carton (2mg 0pt5mg Carton)

2mg-0pt5mg-carton (2mg 0pt5mg Carton)
FDA Label Image

2mg-0pt5mg-pouch (2mg 0pt5mg Pouch)

2mg-0pt5mg-pouch (2mg 0pt5mg Pouch)
This text contains information about a medication called "Buprenorphine and Naloxone Sublingual Film," which is used to treat opioid dependence. It warns about keeping the medication out of reach of children and the need for emergency medical care if accidentally ingested. The text also advises against cutting, chewing, or swallowing the sublingual film. The medication is available by prescription only.*
FDA Label Image

4mg-1mg-carton (4mg 1mg Carton)

4mg-1mg-carton (4mg 1mg Carton)
FDA Label Image

4mg-1mg-pouch (4mg 1mg Pouch)

4mg-1mg-pouch (4mg 1mg Pouch)
FDA Label Image

8mg-2mg-carton (8mg 2mg Carton)

8mg-2mg-carton (8mg 2mg Carton)
This is a description of a medication guide for Buprenorphine and Naloxone Sublingual Film. It provides instructions for pharmacists to dispense the guide to each patient and highlights the importance of keeping the film out of reach of children to avoid accidental ingestion. The guide also emphasizes not cutting, chewing, or swallowing the film. It includes information on the proper administration of the sublingual film and warns about the need for emergency medical care in case of accidental ingestion by children.*
FDA Label Image

8mg-2mg-pouch (8mg 2mg Pouch)

8mg-2mg-pouch (8mg 2mg Pouch)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Structure-buprenorphine (Structure Buprenorphine)

Structure-buprenorphine (Structure Buprenorphine)
FDA Label Image

Structure-naloxone (Structure Naloxone)

Structure-naloxone (Structure Naloxone)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.